Rigel Pharmaceuticals Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Rigel Pharmaceuticals Inc inventory turnover ratio, the Rigel Pharmaceuticals Inc's ability to sell and replace its inventory in the second quarter 2026, sequentially increased to 1.88 in the second quarter 2026, RIGL's markets remain strong, its supply chain continue to be in a grate shape.Average inventory processing period, for the Rigel Pharmaceuticals Inc in Jun 30 2026 quarter, has decreased to 194 days, compare to 216 days, in the Mar 31 2026 quarter.

Within Healthcare sector 218 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1391 in the first quarter 2026, to 1660.

RIGL Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Rigel Pharmaceuticals Inc Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

RIGL Inventory Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Inventory Growth	37.84 %	150.1 %	91.7 %	178.07 %	29.33 %
Y / Y Cost of Sales Growth	89.28 %	4.47 %	2.87 %	-40.78 %	60.46 %
Inventory Turnover Ratio (TTM)	1.88	1.69	1.97	2.26	3.51
RIGL's Total Ranking	# 1660	# 1391	# 1117	# 918	# 938
Average inventory processing period	195	216	186	161	104
Seq. Inventory Growth	23.3 %	1.27 %	-13.51 %	27.63 %	123.72 %
Seq. Cost of Sales Growth	85.08 %	-22.65 %	25.29 %	5.53 %	2.15 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 61
Healthcare Sector	# 219
Overall Market	# 1660

Inventory Turnover Ratio Statistics
High	Average	Low
3.58	1.06	0.13
(Mar 31 2025)		(Mar 31 2022)

RIGL Company Profile >> Back to RIGL Efficiency Comparisons >> Compare RIGL Inventory Turnover Ratio to its Competitors

Financial Statements
Rigel Pharmaceuticals Inc's Inventories	$ 14 Millions	Visit RIGL's Balance sheet
Rigel Pharmaceuticals Inc's Cost of Revenues TTM	$ 24 Millions	Visit RIGL's Income Statement
What are RIGL's Sales?		Visit RIGL's Sales by Segment

Other Inventory Turnover Ratios
Rigel Pharmaceuticals Inc's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
RIGL's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for RIGL's Competitors
Inventory Turnover Ratio for RIGL's Suppliers
Inventory Turnover Ratio for RIGL's Customers

You may also want to know
RIGL's Sales Growth Rates	RIGL's Pe Price to earnings ratio	RIGL's Receivables Turnover Ratio	RIGL's Stock Quote
RIGL's Net Income Growth Rates	RIGL's Ps Price to Sales ratio	RIGL's Sales per Employee	RIGL's Asset Turnover Ratio
RIGL's Net Margin	RIGL's Pb Price to Book ratio	RIGL's Financial Strength Ratios	RIGL's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Jun 30 2026	Inventories at quarter ending Jun 30 2026
Guardant Health Inc	4.53	$ 413.947 Millions	$ 91 Millions
Idexx Laboratories Inc	4.44	$ 1,714.440 Millions	$ 386 Millions
Cryoport inc	4.40	$ 98.679 Millions	$ 22 Millions
Envista Holdings Corporation	4.37	$ 1,278.500 Millions	$ 293 Millions
Myomo Inc	4.23	$ 14.262 Millions	$ 3 Millions
Adc Therapeutics Sa	4.17	$ 5.806 Millions	$ 1 Millions
Scilex Holding Company	4.08	$ 14.867 Millions	$ 4 Millions
Medinotec Inc	4.08	$ 4.736 Millions	$ 1 Millions
Alpha Teknova Inc	4.08	$ 28.288 Millions	$ 7 Millions
3m Company	4.07	$ 15,258.000 Millions	$ 3,754 Millions
Coherus Oncology inc	4.03	$ 15.822 Millions	$ 4 Millions
Electromed Inc	4.02	$ 14.133 Millions	$ 4 Millions
Novocure Limited	4.02	$ 166.921 Millions	$ 41 Millions
Koru Medical Systems Inc	3.97	$ 16.948 Millions	$ 4 Millions
Elite Pharmaceuticals Inc	3.95	$ 78.824 Millions	$ 20 Millions
Lftd Partners Inc	3.89	$ 29.233 Millions	$ 8 Millions
Pmgc Holdings Inc	3.87	$ 1.364 Millions	$ 0 Millions
Sonoma Pharmaceuticals Inc	3.83	$ 13.392 Millions	$ 3 Millions
Intelligent Bio Solutions Inc	3.80	$ 2.165 Millions	$ 1 Millions
Iridex Corp	3.80	$ 32.517 Millions	$ 9 Millions
Biocryst Pharmaceuticals Inc	3.69	$ 20.926 Millions	$ 6 Millions
Teva Pharmaceutical Industries Limited	3.66	$ 8,232.000 Millions	$ 2,250 Millions
Neuraxis Inc	3.55	$ 0.783 Millions	$ 0 Millions
Beyond Air Inc	3.51	$ 6.447 Millions	$ 2 Millions
Nexgel Inc	3.49	$ 7.577 Millions	$ 2 Millions
Lifeward ltd	3.47	$ 13.976 Millions	$ 4 Millions
Tandem Diabetes Care Inc	3.46	$ 456.703 Millions	$ 132 Millions
Mirum Pharmaceuticals Inc	3.40	$ 85.221 Millions	$ 25 Millions
Zai Lab Limited	3.39	$ 195.542 Millions	$ 58 Millions
Bellevue Life Sciences Acquisition Corp	3.38	$ 1.215 Millions	$ 0 Millions

Date modified: 2026-08-31T15:44:59+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.